Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Malaga
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
To be of legal age
Having suffered from primary breast cancer with histological confirmation (I-IIIA)
Completion of primary carcinoma treatment (surgery, chemotherapy, radiotherapy)
To be receiving hormone therapy as an adjunct to the process by aromatase inhibitors (exemestane, anastrozole, letrozole)
To present a functional status according to WHO from 0 (asymptomatic, complete and ambulatory activity) or 1 (symptomatic but completely ambulatory, strenuous physical activity restricted but able to perform sedentary gentle activities)
To understand correctly Spanish
To show their approval by signing the informed consent
Having had musculoskeletal disorders attributable to IA.
Clareo Health | Effect of Kinesiotaping for the Treatment of Hormone-induced Myalgia in Women Given Breast Cancer Survivors
